Canara Robeco Bluechip Equity Fund: Capitalizing on Market Leaders - Outside View by PersonalFN

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Canara Robeco Bluechip Equity Fund: Capitalizing on Market Leaders
Aug 3, 2020

Our buying decisions are often influenced by brand popularity. When it comes to investing in mutual funds, many of us prefer funds that have wide acceptance. However, you would be surprised to know, some of the popular schemes that have completed a long-term track record underperformed the benchmark index as well as the category average returns.

On the contrary, some small-sized, undiscovered funds have the potential to generate superior returns as compared to their large-sized peers. Therefore, it is important to judge mutual funds based on various quantitative and qualitative parameters rather than popularity.

Canara Robeco Bluechip Equity Fund (CRBEF) is one such less known fund that has clearly beaten its giant-sized peers in the recent crash and showcased its high growth potential over the last one year.

--- Advertisement ---
On May 17, we are holding a FREE event to reveal Equitymaster's Great Indian Wealth Project

At this event, we'll reveal the details of your first stock for a potential Rs 7 crore in long-term wealth.

Since there are limited seats, we urge you to register at the earliest.

Click here for free sign-up

Graph 1: Growth of Rs 10,000 if invested in Canara Robeco Bluechip Equity Fund 5 years ago

CRBEF has been an average-performing large cap fund that remained mute for a major tenure of its existence, and managed to deliver returns just in line with the category average. However, the fund's strategy of sticking to index heavy weights that have been driving the index over the last couple of years has turned in its favour and paid-off investors with superior returns. In the recent market crash, the fund managed to limit the downside, generating noticeable alpha over the index, and improved its overall performance as well. Over the last 5-year period, CRBEF has registered a compounded annualised return of around 9.5%, as against 7.2% CAGR delivered by its benchmark S&P BSE 100 - TRI index. Clearly, CRBEF's recent extra-ordinary performance, supported by its ability to manage downsides, helped it find a space in the list of top category performers.

Table: Canara Robeco Bluechip Equity Fund's performance vis-a-vis category peers
Scheme Name Corpus (Cr.) 1 Year (%) 2 Year (%) 3 Year (%) 5 Year (%) 7 Year (%) Std Dev Sharpe
Axis Bluechip Fund 14,522 6.42 4.44 10.46 10.33 14.77 17.12 0.102
Canara Rob Bluechip Equity Fund 533 11.11 5.92 8.73 9.44 13.58 18.48 0.072
BNP Paribas Large Cap Fund 782 6.26 4.98 5.92 7.19 14.33 18.42 0.025
Edelweiss Large Cap Fund 177 4.47 0.68 5.66 7.2 12.74 20.36 0.03
Invesco India Largecap Fund 208 4.64 0.6 5.08 7.74 13.7 20.05 0.019
Mirae Asset Large Cap Fund 16,381 1.49 2.51 5.06 9.44 17.01 21.02 0.025
JM Large Cap Fund 513 6.98 3.75 4.41 5.86 11.85 9.8 -0.029
IDFC Large Cap Fund 439 6.02 0.91 4.35 7.58 10.89 19.74 0.003
Kotak Bluechip Fund 1,502 4.97 1.42 4.35 7.03 12.86 20.98 0.008
LIC MF Large Cap Fund 336 2.71 1.34 3.89 5.77 11.87 18.51 0.004
S&P BSE 100 - TRI   1.01 0.04 4.05 7.19 11.42 21.14 0.012
Returns are point to point and in %, calculated using Direct Plan - Growth option. Those depicted over 1-Yr are compounded annualised.
Data as on July 29, 2020
(Source: ACE MF)

*Please note, this table only represents the best performing funds based solely on past returns and is NOT a recommendation. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator for future returns. The percentage returns shown are only for indicative purposes.

CRBEF's high growth potential is clearly visible in the performance table above. The superior performance registered by the fund over the last year has helped improve its overall returns as well. With this the fund has achieved a mark of significantly outpacing the benchmark and prominent category peers across time periods. Axis Bluechip Fund, BNP Paribas Large Cap Fund, and Edelweiss Large Cap Fund are some of the other top performers in the category.

This outperformance has come at a far reasonable risk when compared to the benchmark and category average. The fund's Standard Deviation (18.48%, annualised) is much lower than its benchmark (21.14%, annualised) as well as the category average. In terms of risk-adjusted returns (as denoted by the Sharpe), CRBEF has shown significant, thus outperforming its benchmark as well as the category average by a noticeable margin.

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth

Investment strategy of Canara Robeco Bluechip Equity Fund

Categorised under large cap funds, CRBEF is mandated to invest a minimum 80% of its assets in large-cap stocks. Accordingly, it focuses on bluechip companies and invests in stocks of companies figuring in the list of top 100 companies, based on market capitalisation.

While selecting stocks for the portfolio, the fund focuses on companies and sectors that are expected to perform better than the general market and uses inputs from an internal quant model to identify investable companies. The fund follows a blend style of investing, i.e. it looks for high growth stocks available at fair valuation and stays invested for the long term.

The fund manager aims to invest in large sized companies with an established business presence, good reputation and solid brand equity. CRBEF usually holds about 35-40 stocks in its portfolio and follows a buy and hold investment strategy, which reflects the strong long-term conviction the fund management has when it picks stocks for the portfolio.

Graph 2: Top portfolio holdings in Canara Robeco Bluechip Equity Fund

CRBEF usually holds a fairly-diversified portfolio of about 35 to 40 stocks. As on June 30, 2020, the fund held 41 stocks in its portfolio spread across sectors. The top 10 stock holdings accounted for about 49.3% of the portfolio. Index heavyweights like HDFC Bank, Reliance Industries, Infosys, and ICICI Bank currently find place in the top 5 portfolio holdings.

In the last one year, the fund benefitted immensely from its holdings in Abbott India, Reliance Industries, Bharti Airtel, Dr Reddy's Lab, Divi's Lab, Nestle India, HUL, etc. However, stocks like L&T, Axis Bank, ICICI Bank, HDFC Bank, ITC, HDFC, etc. eroded some of its gains.

Among sector holdings, CRBEF's portfolio has major exposure to Banking and Finance with a combined allocation of about 30%. Additionally, it has other prominent sectors such as, Consumption, Infotech, Pharma, Petroleum, Auto and Telecom in the portfolio with an exposure of approximately 5% to 15% in each one.


CRBEF has evolved in terms of performance by distinctly outperforming the benchmark, as well as most of its large-sized peers even in depressing conditions. This gives investors the confidence of investing in the fund for the long term. Backed by well-defined investment process, CRBEF has the ability to timely pick quality names having high growth potential, and deliver market-beating returns in the long run at a reasonable level of risk.

However, its high concentration towards few sectors can add to volatility in the short term. It is suitable for long-term investors having preference for stability of large caps along with potential to generate decent alpha in terms of returns.

Editor's note: The last few years have not been among the best for equity mutual funds. While most funds have underperformed or are struggling to match the returns of the benchmark, there are few funds that have the potential to constantly generate alpha for its investors. And we have identified five such high alpha generating funds, in our latest report 'The Alpha Funds Report 2020'. Do not miss our latest research finding. Get your access to this exclusive report, right here!

Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.

Author: Divya Grover

This article first appeared on PersonalFN here.

Join Now: PersonalFN is now on Telegram. Join FREE Today to get 'Daily Wealth Letter' and Exclusive Updates on Mutual Funds

PersonalFN is a Mumbai based personal finance firm offering Financial Planning and Mutual Fund Research services.


The views mentioned above are of the author only. Data and charts, if used, in the article have been sourced from available information and have not been authenticated by any statutory authority. The author and Equitymaster do not claim it to be accurate nor accept any responsibility for the same. The views constitute only the opinions and do not constitute any guidelines or recommendation on any course of action to be followed by the reader. Please read the detailed Terms of Use of the web site.

Equitymaster requests your view! Post a comment on "Canara Robeco Bluechip Equity Fund: Capitalizing on Market Leaders". Click here!


More Views on News

How Did Mindtree Perform in Q4FY21? (Company Info)

Apr 20, 2021

Here's the rundown on the company's latest quarterly results.

Tata Dividend Yield Fund: Seizes Opportunities from High Dividend Yield Stocks (Outside View)

May 7, 2021

PersonalFN analyses the features of Tata Dividend Yield Fund and explains the potential this fund has to offer to its investors.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

Axis Healthcare ETF: Seeking Capital Appreciation from Sectoral Exposure (Outside View)

May 6, 2021

PersonalFN analyses the features of Axis Healthcare ETF and explains the potential this fund has to offer to its investors.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


May 7, 2021 03:06 PM